Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palmyra CBD, a division of REW Ventures, LLC, is a San Diego-based contract development and manufacturing organization (CDMO) specializing in advanced cannabinoid and nutraceutical formulations. The company utilizes its proprietary PhytoNano™ Adsorption Technology to transform lipophilic botanical extracts into high-bioavailability, pharmaceutical-grade water-soluble powders. Palmyra offers a comprehensive suite of services, including R&D, custom formulation, and large-scale production of topicals, tinctures, gummies, and pet wellness products. Their operations are conducted in GMP-compliant and FDA-registered facilities, serving clients in the wellness, skincare, and clinical research sectors with a focus on precision dosing and botanical integrity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palmyra CBD.